 Globe and Mail | A Stem-Cell-Based Drug Gets Approval in Canada New York Times The company, Osiris Therapeutics of Columbia, Md., said Thursday that Canadian regulators had approved its drug Prochymal, to treat children suffering from graft-versus-host disease, a potentially deadly complication of bone marrow transplantation. World's First Approved Stem Cell Drug; Osiris Receives Marketing Clearance ... Osiris stem-cell therapy wins Canadian approval |
